---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-027233"
form_type: "8-K"
ticker: "TVRD"
cik: "0001346830"
company_name: "Tvardi Therapeutics, Inc."
filed_at: "2025-03-24T23:59:59+00:00"
generated_at: "2026-05-24T06:23:04.183876+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Cara issues supplemental disclosures for Tvardi merger after stockholder lawsuits

## Summary
- Received 13 demands and 2 lawsuits (filed Mar 5-6, 2025) claiming proxy omitted material info.
- Combined company board to have 5 Tvardi designees, 1 Cara designee (Susan Shiff), 1 vacancy.
- Piper Sandler valuation analyses updated with detailed peer comparisons and IPO precedent tables.
- Cara denies violations but provides supplements to avoid litigation expense and merger disruption.

## SEC filing metadata
- accession: 0001104659-25-027233
- form_type: 8-K
- ticker: TVRD
- cik: 0001346830
- company_name: Tvardi Therapeutics, Inc.
- filed_at: 2025-03-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1346830/000110465925027233/0001104659-25-027233-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1346830/000110465925027233/tm259994d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-027233
- JSON: https://secwatch.observer/filing/0001104659-25-027233.json
- Plain text: https://secwatch.observer/filing/0001104659-25-027233.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.